United States · FDA National Drug Code directory
Carbidopa and Levodopa
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75907-022_3f6116d8-a60c-f7fe-c73c-b6ed1361b67f
- Product NDC
- 75907-022
- Form
- TABLET
- Composition / generic term
- Carbidopa and Levodopa
- Labeler
- Dr. Reddy's Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240501
- Source listing expiry
- 20271231
Source-listed ingredients
- CARBIDOPA — 10 mg/1
- LEVODOPA — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (75907-022-01) · 75907-022-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →